Physician profile

Dan Jones

Foot & Ankle Surgery · Duncaville, TX

NPI 1942200662

$10,268.63

in general payments reported to CMS, 2019-2025

41 companies · $679 in 2025

The $679 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,519.21
Travel and Lodging$580.80

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $3,534.31 2019-2023 Prophecy, Inbone, Invision
Medical Device Business Services, INC. $1,108.60 2019
Depuy Synthes Sales INC. $895.49 2019-2024 Motoband, N/A
Wright Medical Technology, INC. $664.56 2019-2020
Treace Medical Concepts, INC. $473.80 2020-2022
Smith+Nephew, INC. $396.25 2019-2025 Evos, Collagenase Santyl
Bard Peripheral Vascular, INC. $328.97 2019
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $258.88 2021-2025 Lifevest
Paratek Pharmaceuticals, INC. $244.52 2020-2025 Nuzyra
Medshape, INC. $190.46 2024 Dynanail
Acera Surgical, INC. $187.48 2021-2025 Restrata Wound Matrix
Integra Lifesciences Corporation $174.09 2024 Integra, Primatrix, Integra Dermal Regeneration Template
Shockwave Medical, INC $170.85 2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Kerecis Limited $159.57 2023 Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen
Pulmonx Corporation $151.74 2025 Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $130.06 2019-2024 Verquvo
Tactile Systems Technology INC $129.95 2019-2023 Flexitouch Plus, Entre Plus
Polynovo North America LLC $128.66 2025 Novosorb Btm
Alnylam Pharmaceuticals INC. $128.39 2025 Onpattro
Anika Therapeutics, INC. $117.09 2022
Ortho Dermatologics, A Division of Bausch Health US, LLC $115.27 2022
Ossio INC $94.95 2021
Misonix INC $65.04 2019
Organogenesis INC. $55.17 2019-2021
Acell, INC. $45.36 2019-2020
Stability Biologics, LLC $41.25 2023
Normatec Industries, LP $34.99 2019-2020
Contego Medical, INC $24.38 2024
Pacira Pharmaceuticals Incorporated $23.99 2020
Cardiovascular Systems INC. $22.67 2019
Abbott Laboratories $20.01 2024 Eterna
Zyla Life Sciences, INC. $18.65 2020
Nabriva Therapeutics, Plc $18.46 2022
Nevro Corp. $17.41 2023 Senza
Orpyx Medical Technologies US INC. $15.54 2023 Orpyx Si
Amgen INC. $15.35 2024 Krystexxa
Novum Pharma, LLC $14.82 2019
Convatec INC. $14.03 2023
Orthofix Medical, INC. $13.75 2020
Sanara Medtech INC. $13.70 2022
Cpm Medical Consultants, LLC $10.12 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Dan Jones

$10,268.63

in general payments reported 2019-2025

Years
2019-2025
Top company
Stryker Corporation
Context
The $679 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/269603/dan-jones

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.